# Immix Biopharma, Inc.: Form 10-Q/A for the period ended Mar 31, 2025

- Company: [Immix Biopharma, Inc.](/companies/immx.md) (CIK 1873835)
- Form: 10-Q/A
- Filed: 2025-05-19
- Accepted by EDGAR: May 19, 2025, 17:23 ET
- Period: 2025-03-31
- Accession: 0001641172-25-011519
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1873835/000164117225011519/form10-qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1873835/000164117225011519/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1873835/000164117225011519/form10-qa.htm

Filed May 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-011519. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.